Literature DB >> 11504407

Binding of Plasmodium falciparum-infected erythrocytes to soluble platelet endothelial cell adhesion molecule-1 (PECAM-1/CD31): frequent recognition by clinical isolates.

A Heddini1, Q Chen, J Obiero, O Kai, V Fernandez, K Marsh, W A Muller, M Wahlgren.   

Abstract

Platelet-endothelial cell adhesion molecule-1 or CD31 (PECAM-1/CD31) is a receptor recognized by Plasmodium falciparum-parasitized erythrocytes (pRBCs). Fluorescence-labeled soluble recombinant PECAM-1/CD31 (sPECAM-1/CD31) is shown to bind to the surface of P. falciparum-infected erythrocytes on up to 70% of the cells. Binding is blocked by the addition of the unlabeled receptor in a dose-dependent fashion, but not by unrelated receptor-proteins. A significant correlation was found between the binding of sPECAM-1/CD31 to pRBCs and the binding to transfected L cells expressing the receptor as seen with six different P. falciparum lines or clones. Panning of cultures on PECAM-1/CD31 transfected L cells was paralleled by an increase in the binding of sPECAM-1/CD31. The pRBCs of 54% of fresh patient-isolates bound sPECAM-1/CD31 with a mean rate of 12.9% (range = 1.1-44%). The data suggest that PECAM-1/CD31 is a common receptor recognized by wild isolates and that the soluble PECAM-1/CD31 suspension assay is a sensitive and reliable way to study PECAM-1/CD31 binding.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11504407     DOI: 10.4269/ajtmh.2001.65.47

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  11 in total

Review 1.  Malaria adhesins: structure and function.

Authors:  Brian M Malpede; Niraj H Tolia
Journal:  Cell Microbiol       Date:  2014-03-06       Impact factor: 3.715

Review 2.  The contribution of Plasmodium chabaudi to our understanding of malaria.

Authors:  Robin Stephens; Richard L Culleton; Tracey J Lamb
Journal:  Trends Parasitol       Date:  2011-11-17

Review 3.  Variant surface antigens of Plasmodium falciparum and their roles in severe malaria.

Authors:  Mats Wahlgren; Suchi Goel; Reetesh R Akhouri
Journal:  Nat Rev Microbiol       Date:  2017-06-12       Impact factor: 60.633

4.  Association of PECAM1/CD31 polymorphisms with cerebral malaria.

Authors:  Jun Ohashi; Izumi Naka; Hathairad Hananantachai; Jintana Patarapotikul
Journal:  Int J Mol Epidemiol Genet       Date:  2016-06-01

5.  Plasmodium falciparum-infected erythrocytes adhere both in the intervillous space and on the villous surface of human placenta by binding to the low-sulfated chondroitin sulfate proteoglycan receptor.

Authors:  Arivalagan Muthusamy; Rajeshwara N Achur; Veer P Bhavanandan; Genevieve G Fouda; Diane W Taylor; D Channe Gowda
Journal:  Am J Pathol       Date:  2004-06       Impact factor: 4.307

6.  Fresh isolates from children with severe Plasmodium falciparum malaria bind to multiple receptors.

Authors:  A Heddini; F Pettersson; O Kai; J Shafi; J Obiero; Q Chen; A Barragan; M Wahlgren; K Marsh
Journal:  Infect Immun       Date:  2001-09       Impact factor: 3.441

7.  Cytoadherence phenotype of Plasmodium falciparum-infected erythrocytes is associated with specific pfemp-1 expression in parasites from children with cerebral malaria.

Authors:  Talleh Almelli; Nicaise T Ndam; Sem Ezimegnon; Maroufou J Alao; Charles Ahouansou; Gratien Sagbo; Annick Amoussou; Philippe Deloron; Rachida Tahar
Journal:  Malar J       Date:  2014-08-25       Impact factor: 2.979

Review 8.  Adhesion of Plasmodium falciparum-infected erythrocytes to human cells: molecular mechanisms and therapeutic implications.

Authors:  J Alexandra Rowe; Antoine Claessens; Ruth A Corrigan; Mònica Arman
Journal:  Expert Rev Mol Med       Date:  2009-05-26       Impact factor: 5.600

9.  Plasmodium falciparum expressing domain cassette 5 type PfEMP1 (DC5-PfEMP1) bind PECAM1.

Authors:  Sanne S Berger; Louise Turner; Christian W Wang; Jens E V Petersen; Maria Kraft; John P A Lusingu; Bruno Mmbando; Andrea M Marquard; Dominique B A C Bengtsson; Lars Hviid; Morten A Nielsen; Thor G Theander; Thomas Lavstsen
Journal:  PLoS One       Date:  2013-07-09       Impact factor: 3.240

10.  Differences in PfEMP1s recognized by antibodies from patients with uncomplicated or severe malaria.

Authors:  Michael F Duffy; Rintis Noviyanti; Takafumi Tsuboi; Zhi-Ping Feng; Leily Trianty; Boni F Sebayang; Eizo Takashima; Fransisca Sumardy; Daniel A Lampah; Louise Turner; Thomas Lavstsen; Freya J I Fowkes; Peter Siba; Stephen J Rogerson; Thor G Theander; Jutta Marfurt; Ric N Price; Nicholas M Anstey; Graham V Brown; Anthony T Papenfuss
Journal:  Malar J       Date:  2016-05-05       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.